Japan Govt to Push Ahead with Off-Year Survey, Considering COVID-19 Impact to Decide on Re-Pricing

Japan will be pressing ahead after all with a drug price survey this autumn towards “off-year” re-pricing in FY2021, while looking at the impact of COVID-19 to actually decide on what to do with the price revision itself, informed sources...read more